[Birmingham, AL, September 18, 2025 ] — Acclinate, the health equity company pioneering community-powered engagement and inclusive clinical trial enrollment, has been named to the Inc. 5000, the annual ranking of the fastest-growing private companies in the United States. The 2025 list was announced last month by Inc. Magazine. 

This milestone marks the second consecutive year Acclinate has earned a spot on the list, with the company ranking No. 3 in Birmingham, No. 6 in Alabama, and No. 9 in healthcare nationwide. The recognition underscores the organization’s sustained growth and its role in shaping the future of equitable clinical research. 

Remarking on the role of deep partnerships, Del Smith, Co-Founder and CEO of Acclinate, said: 

“This recognition is truly a reflection of our customers. They believe in our product, they believe in our solution, and they’ve been willing not only to continue doing business with us but to grow with us over the years. We’ve been fortunate to have that trust, along with the support of our team, investors, and community—and that’s what makes this achievement possible."

Tiffany Whitlow, Co-Founder and Chief Development Officer of Acclinate, added:

“Our growth has always been fueled by collaboration. From the beginning, anchor partners like Innovate Alabama have believed in our vision and helped us prove that community-powered engagement can reshape clinical research. This recognition from Inc. is a celebration not only of Acclinate, but of the communities and partners who continue to walk with us as we advance health equity together.”

Through its NOWINCLUDED community and tech-enabled e-DICT platform, Acclinate helps sponsors and CROs engage diverse populations, mobilize participation, and generate more equitable research outcomes. The company’s ongoing growth highlights the increasing demand for community-centered approaches to inclusive clinical trials. 

The full results of the Inc. 5000, including company profiles and an interactive database, can be found at www.inc.com/inc5000. 

About Acclinate 

Acclinate is a health equity company that helps pharmaceutical companies and healthcare organizations reach and engage diverse communities in clinical research. Through culturally relevant engagement and innovative technology, Acclinate empowers communities to take action for better health and ensures clinical trials reflect the populations they aim to serve. 

For media inquiries or additional information, please contact:

Lauren Clements 
Head of Marketing 
Acclinate
lauren@acclinate.com
256-435-2800

Media Placement